Enhancing immune responses to improve HIV vaccines
Potent Boosting of Tfh1 Cells to Enhance HIV-1 Vaccine Efficacy
This study is working on creating better HIV vaccines by testing them in monkeys to see how well they can help the immune system fight off the virus, with the hope of eventually helping people stay healthy and prevent HIV infection.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Tulane University of Louisiana NIH-funded |
| Lab location | 1 site (New Orleans, United States) |
| Project ID | NIH-11179544 on NIH RePORTER |
What this research studies
This research focuses on developing effective HIV vaccines by utilizing nonhuman primates (NHPs) in preclinical studies. The program aims to evaluate candidate AIDS vaccines through thorough assessments of immune responses, testing vaccine efficacy, and identifying factors that reduce the risk of HIV infection. By providing resources for housing and maintaining NHPs, the research supports all stages of AIDS vaccine development, from initial evaluations to clinical testing. The goal is to create vaccines that can generate strong immune responses to prevent or control HIV infection.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals at high risk for HIV infection who may benefit from improved vaccine strategies.
Not a fit: Patients who are already living with HIV or those who do not have a risk of exposure to the virus may not receive benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of more effective HIV vaccines that significantly reduce the risk of infection.
How similar studies have performed: Previous research using similar approaches with nonhuman primates has shown promise in enhancing vaccine efficacy, indicating potential for success in this area.
Where this research is happening
New Orleans, United States
- Tulane University of Louisiana — New Orleans, United States (Active)
Researchers
- Principal investigator: Aye, Pyone — Tulane University of Louisiana
- Study coordinator: Aye, Pyone
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.